Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection

Area of Science:

• Hepatology
• Immunology
• Virology

Background:

• Chronic hepatitis C virus (HCV) infection is associated with various organ-specific and systemic autoimmune diseases, notably cryoglobulinemia.
• Evidence links HCV to Sjögren's syndrome, rheumatoid arthritis, and lupus, alongside hematological disorders like cytopenias and B-cell lymphoma.
• Extrahepatic manifestations, including endocrine, metabolic, cardiovascular, and neuropsychiatric issues, negatively impact prognosis and quality of life.

Purpose of the Study:

• To review the association between chronic HCV infection and autoimmune diseases.
• To highlight the spectrum of extrahepatic manifestations in HCV patients.
• To discuss the impact of direct-acting antiviral therapies (DAAs) on HCV complications.

Main Methods:

• Review of experimental, virologic, and clinical evidence.
• Analysis of epidemiological data on HCV-associated conditions.
• Synthesis of current understanding of HCV pathophysiology and treatment outcomes.

Main Results:

• HCV infection frequently co-occurs with autoimmune conditions, particularly cryoglobulinemia, Sjögren's syndrome, rheumatoid arthritis, and lupus.
• Hematological disorders, including cytopenias and B-cell lymphomas, are more prevalent in HCV-infected individuals.
• Numerous extrahepatic manifestations affect patient prognosis and quality of life, but DAAs show promise for cure.

Conclusions:

• Chronic HCV infection presents a significant risk for developing systemic autoimmune and hematological diseases.
• Extrahepatic manifestations significantly influence patient health outcomes and require comprehensive management.
• Direct-acting antiviral therapies (DAAs) represent a breakthrough in curing HCV and mitigating its diverse complications.